GOSSVSOBIO• 28 Days (Normalized)
GOSS vs OBIO (Gossamer Bio Inc. vs Orchestra BioMed Holdings Inc.)
Showing Closing Date Range from Aug, 17 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GOSS Performance $10.7
+7542.86%
Gossamer Bio Inc.
Normalized Baseline0.00%
OBIO Performance $5.9
+25%
Orchestra BioMed Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
+7517.86%
GOSS outperforming by 7517.86%
GOSSOBIO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GOSS OBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | GOSS Price | GOSS Gain (%) | OBIO Price | OBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $10.70 | +7542.86% | $5.90 | +25.00% | +7517.86% |
| Sep 11, 2026 | $10.73 | +7564.29% | $6.12 | +29.66% | +7534.63% |
| Sep 10, 2026 | $11.36 | +8014.29% | $5.81 | +23.09% | +7991.20% |
| Sep 09, 2026 | $12.80 | +9042.86% | $5.45 | +15.47% | +9027.39% |
| Sep 08, 2026 | $14.40 | +10185.71% | $5.43 | +15.04% | +10170.67% |
| Sep 04, 2026 | $14.00 | +9900.00% | $5.08 | +7.63% | +9892.37% |
| Sep 03, 2026 | $14.05 | +9934.29% | $4.74 | +0.42% | +9933.87% |
| Sep 02, 2026 | $0.17 | +23.57% | $4.95 | +4.87% | +18.70% |
| Sep 01, 2026 | $0.17 | +19.29% | $4.90 | +3.81% | +15.48% |
| Aug 31, 2026 | $0.17 | +21.43% | $5.04 | +6.78% | +14.65% |
| Aug 28, 2026 | $0.17 | +21.43% | $5.19 | +9.85% | +11.58% |
| Aug 27, 2026 | $0.17 | +21.43% | $5.11 | +8.26% | +13.17% |
| Aug 26, 2026 | $0.17 | +24.29% | $5.26 | +11.44% | +12.85% |
| Aug 25, 2026 | $0.21 | +46.43% | $5.36 | +13.56% | +32.87% |
| Aug 24, 2026 | $0.18 | +25.00% | $5.44 | +15.25% | +9.75% |
Page 1 of 2